1-May-2026
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Business Wire (Fri, 1-May 8:30 AM ET)
Quantum-Si Announces Successful Sequencing on Integrated Proteus Instruments
Business Wire (Tue, 28-Apr 8:30 AM ET)
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
Business Wire (Thu, 16-Apr 8:30 AM ET)
QSI’s Single-Molecule Protein Sequencing Enables Key Cancer Research Breakthrough
Market Chameleon (Wed, 15-Apr 7:44 AM ET)
Business Wire (Wed, 15-Apr 8:30 AM ET)
Business Wire (Tue, 14-Apr 8:30 AM ET)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 10-Apr 5:30 PM ET)
Quantum-Si Announces First Customer Samples Tested on the Proteus Prototype System
Business Wire (Wed, 8-Apr 9:15 AM ET)
Quantum-Si Announces the Start of the Proteus Roadshow
Business Wire (Mon, 6-Apr 9:40 AM ET)
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
Business Wire (Tue, 3-Mar 4:05 PM ET)
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Quantum-Si - Class A trades on the NASDAQ stock market under the symbol QSI.
As of May 1, 2026, QSI stock price declined to $0.96 with 3,414,468 million shares trading.
QSI has a beta of 2.85, meaning it tends to be more sensitive to market movements. QSI has a correlation of 0.19 to the broad based SPY ETF.
QSI has a market cap of $206.48 million. This is considered a Small Cap stock.
Last quarter Quantum-Si - Class A reported $451,000 in Revenue and -$.08 earnings per share. This fell short of revenue expectation by $-358,200 and exceeded earnings estimates by $.05.
In the last 3 years, QSI traded as high as $5.77 and as low as $.61.
The top ETF exchange traded funds that QSI belongs to (by Net Assets): ARKG, VTI, IWM, VXF, IWN.
QSI has underperformed the market in the last year with a price return of -17.4% while the SPY ETF gained +30.4%. QSI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.2% and -10.4%, respectively, while the SPY returned +4.4% and +1.5%, respectively.
QSI support price is $.92 and resistance is $1.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QSI shares will trade within this expected range on the day.